Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

BonAlive Granules

K-Number: K191274 · 2019-08-07

Decision Date2019-08-07
Product CodeMQV
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

BonAlive Granules is a medical device manufactured by Bonalive Biomaterials, Ltd.. It received FDA 510(k) clearance on 2019-08-07 under approval number K191274. The device is classified under product code MQV. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the BonAlive Granules?

BonAlive Granules is a medical device that received FDA 510(k) clearance on 2019-08-07. It is manufactured by Bonalive Biomaterials, Ltd.. The 510(k) number is K191274.

When was BonAlive Granules approved by the FDA?

BonAlive Granules received FDA 510(k) clearance on 2019-08-07, under approval number K191274.

What company makes BonAlive Granules?

BonAlive Granules is manufactured by Bonalive Biomaterials, Ltd..

What is the FDA product code for BonAlive Granules?

The FDA product code for BonAlive Granules is MQV.

Other Devices by Bonalive Biomaterials, Ltd.

Related Devices (Code: MQV)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.